The Pharmaceutical Journal,
August 5, 2000

Back issues

Comment

An Onlooker's Notebook   180

• Ancient food crops
• Oxygen on the mountain
• Eating the aged

Leading Article   181

• Promising plan

News   182-185

• Alternative contracts for community pharmacies proposed in NHS plan 182
• Ten-year modernisation plan for NHS 182-183
• Profession waits to see details of NHS plan for pharmacy 183
• Society to be part of regulators' council 184
• Meaning of "medicines management" 184
• White Paper promises greater investment in science 184
• Boots to boost organ donors 184
• Category D 184
• NPA board: Welcome for EC's proposed food supplement safety measures 185
• Council member queries status of Society pay body 185
• Judge upholds three-attempts-only exam rule 185
• Legislation for patient group directions 185

Clinical Pharmacy   186-188

• Concerns raised over secret drug administration by carers 186
• Combination NRT gives higher cessation rate, study finds 186
• Inequality in cancer treatment 187
• Gene therapy and drug combination for cancer? 187
• Advice to patients: (44) Simvastatin 187
• Asthma guidelines to be updated 187
• Etanercept for psoriatic rheumatoid arthritis? 188
• New photosensitising drug for "wet", age-related macular degeneration 188
• Targeting influenza 188
• Sodium cromoglicate for sickle cell disease 188

Business   189

• Pharmacy Partners offers daily cash payments for NHS dispensing 189
• AU expands in Europe 189
• Glaxo "firing on all cylinders" 189

The Society   190

• Further media training for branch PROs 190
• Society congratulates Queen Mother on her 100th birthday 190
• MEP guide: August amendments 190
• Obituaries 190

Broad Spectrum   191

Reinventing the wheel - again! (T. Furber) 191

Letters to the Editor   192-193

• The Journal
  • Interesting letters 192
  • A no-win situation 192
  • Meat and poison 192
• Registration examination - Failure patterns? 192
• Veterinary medicines - Personal thoughts 192
• Calcichew - Price explanation 193
• Information leaflets - Unsatisfactory 193
• The NHS - Where was pharmacy? 193

Special Feature   194-205

• Pharmaceutical care: (9) Coronary heart disease (S. McGlynn et al) 194-205

Articles   206-210

• The drug development process: 4. Quality issues (II) (R. J. Harman) 206-208
• Pierre Fabre: a very French company (M. Summerhayes) 209-210

Forum   211-212

• Penn Lecture: Gene therapy - the big picture 211-212

Products   213

• Visudyne infusion 213
• Adgyn tablets 213
• Discontinued 213
• Recall - Targocid 400mg 213
• Labels update 213
• Price changes 213

Notice-Board   214

• Official notices 214
• Appointments 214
• About people 214
• Personal 214
• Garden party 214

Front Cover Picture

Our front cover photograph shows Mr Alan Milburn (Secretary of State for Health) at the press conference that followed the launch of the Government's NHS plan for England on July 27. Report (p182). Professional bodies' guarded welcome (p183). Leading article (p181).

Cash payments

A new business service for pharmacy contractors is offering to make daily cash payments based on their NHS dispensing (p189).

Congratulations

The Society has received thanks from Queen Elizabeth the Queen Mother for the congratulations and good wishes it sent to Her Majesty to mark her 100th birthday (p190).

Coronary heart disease

Our series of special features on pharmaceutical care continues this week with an article on coronary heart disease (p194).

Quality issues

Further aspects of quality criteria are discussed in the fourth article in our series on the drug development process (p206).

Pierre Fabre

This week we carry a report of a visit by British oncology pharmacists to Pierre Fabre, a French company best known for its vinca alkaloid vinorelbine (p209).